As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...

Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe ...

GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

IQVIA has better operating margins, operational efficiency, strong cash flows, and moderate leverage. See why IQV stock is a ...

Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...

Parker Hannifin is playing a key role in enhancing biopharma manufacturing training in Europe, through a new partnership with ...

On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...

Veradermics Inc., a New Haven-based biopharmaceutical company, said Wednesday it has closed a $75 million Series B financing ...

A Maryland jury has convicted both former CytoDyn CEO Nader Pourhassan, Ph.D., and ex-Amarex CEO Kazem Kazempour on several ...

Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.

Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...